vimarsana.com

Latest Breaking News On - Armaceutiche - Page 1 : vimarsana.com

Menarini Industrie Farmaceutiche Riunite: Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma

Data demonstrate a significant 71% reduction in risk of disease progression or death in selinexor + bortezomib + dexamethasone (SVd) arm versus bortezomib + dexamethasone (Vd) arm in PI-naïve

United statesUnited kingdomNorthern irelandCastillay leópMecklenburg vorpommernElcin barker ergunMaria victoria mateosStefan klotterMenarini groupStemline therapeutics incKaryopharm therapeutics incEuropean hematology associationEuropean commissionWorld health organizationUniversity hospital salamancaStemline therapeutics

Menarini Industrie Farmaceutiche Riunite: Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer

United statesElcin barker ergunGewinn nurMenarini groupAmerican society of clinical oncologyRadius health incUt health san antonioStemline therapeutics incUs food drug administrationMd anderson cancer centerEuropean medicines agencyStemline therapeuticsAmerican societyClinical oncologyAnnual meetingDrug administration

Menarini Industrie Farmaceutiche Riunite: A Menarini Diagnostics announces the release of the PRIME MDx platform

FLORENCE, Italy, May 22, 2023 /PRNewswire/ A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated

United arab emiratesPrnewswirea menariniWorldlab euromedlabGewinn nurFabio piazzalungaMenarini pharmaceutical groupHuman touch of technologyMenarini diagnosticsGeneral managerGlobal headDiagnostics divisionMedlab middle eastHuman touch

Menarini Industrie Farmaceutiche Riunite: BOTTICELLI, THE INQUIETUDE AND THE BEAUTY - Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance

FLORENCE, Italy, May 15, 2023 /PRNewswire/ Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master

Mantegna madonna delleSandro botticelliSanta croceAlberto giovanni aleottiMariano filipepiCristina acidiniEugenio gianiGirolamo savonarolaPalazzo pucciMenarini youtubeTrinity pala delleElcin barker ergun menarini groupLucia aleotti menarini group shareholderMenarini groupCarlo colombini menarini group board memberEric cornut menarini group

Menarini Industrie Farmaceutiche Riunite: Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting

FLORENCE, Italy and NEW YORK, May 9, 2023 /PRNewswire/ The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics ("Stemline"), a

United statesElcin barker ergunBreast cancer congressMenarini groupAmerican society of clinical oncologyStemline therapeutics incEuropean society for medical oncologyRadius health incUs food drug administrationEuropean medicines agencyMenarini group stemline therapeuticStemline therapeuticsMedical oncologyClinical oncologyStemline therapeuticCancer congress

vimarsana © 2020. All Rights Reserved.